Clinical Trial Update: Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of talsaclidine in patients with mild to moderate Alzheimer's disease has completed. The update reports the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Talsaclidine (Talsaclidine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED